Active Ingredient(s): Loteprednol Etabonate
FDA Approved: * October 26, 2020
Pharm Company: * KALA PHARMS INC
Category: Allergies, Cough & Cold

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. It was patented in 1980 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Furt... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Eysuvis 2.5 mg/ml Ophthalmic Suspension/ Drops
NDC: 71571-333
Alcon Laboratories, Inc.

Related Brands

Drugs with the same active ingredients